assembly_id	genome_id	genome_def	crispr_array_locus_merge	crispr_array_location_merge	crispr_locus_id	crispr_pred_method	array_in_prot	prot_within_array_20000	prot_in_genome	crispr_type_by_cas_prot	consensus_repeat	repeat_length	self-targeting_spacer_number	self-targeting_target_number	spacer_location	protospacer_location	repeat_type	spacer_locus_num	spacer_num	correct_crispr_type	genome_cas_prots	unknown_protein_around_crispr	L10	L10_domain	L9	L9_domain	L8	L8_domain	L7	L7_domain	L6	L6_domain	L5	L5_domain	L4	L4_domain	L3	L3_domain	L2	L2_domain	L1	L1_domain	R1	R1_domain	R2	R2_domain	R3	R3_domain	R4	R4_domain	R5	R5_domain	R6	R6_domain	R7	R7_domain	R8	R8_domain	R9	R9_domain	R10	R10_domain
GCF_001188855.1_ASM118885v1	NZ_CP009470	Staphylococcus schleiferi strain 1360-13 chromosome, complete genome	1	1478881-1481291	1,1,1	CRISPRCasFinder,CRT,PILER-CR	no	cas2,cas1,cas9	RT,WYL,DEDDh,cas3,DinG,cas2,cas1,cas9,csa3	 or Type II-C?,Type II-B,Type II-A,Type II-C, Type II-B	GTTTCATTTATACCTAAAATTACAGAGTACTAAAAC,GTTTCATTTATACCTAAAATTACAGAGTACTAAAAC,GTTTCATTTATACCTAAAATTACAGAGTACTAAAAC	36,36,36	0	0	NA	NA	NA:NA:NA	36,36,13	36	orTypeII-C?,TypeII-B,TypeII-A,TypeII-C,TypeII-B	RT,WYL,DEDDh,cas3,DinG,cas2,cas1,cas9,csa3	NA|105aa|up_8|NZ_CP009470.1_1469372_1469687_+,NA|198aa|up_2|NZ_CP009470.1_1475856_1476450_-,NA|284aa|up_0|NZ_CP009470.1_1477510_1478362_+,NA|337aa|down_0|NZ_CP009470.1_1481465_1482476_-,NA|69aa|down_7|NZ_CP009470.1_1490471_1490678_+,NA|88aa|down_8|NZ_CP009470.1_1491880_1492144_+	NA|485aa|up_9|NZ_CP009470.1_1467686_1469141_+	COG0833, LysP, Amino acid transporters [Amino acid transport and metabolism]	NA|105aa|up_8|NZ_CP009470.1_1469372_1469687_+	NA	NA|269aa|up_7|NZ_CP009470.1_1469861_1470668_-	pfam08282, Hydrolase_3, haloacid dehalogenase-like hydrolase	NA|307aa|up_6|NZ_CP009470.1_1471002_1471923_-	PRK01212, PRK01212, homoserine kinase; Provisional	NA|355aa|up_5|NZ_CP009470.1_1471919_1472984_-	PRK07409, PRK07409, threonine synthase; Validated	NA|428aa|up_4|NZ_CP009470.1_1472989_1474273_-	PRK06349, PRK06349, homoserine dehydrogenase; Provisional	NA|451aa|up_3|NZ_CP009470.1_1474464_1475817_+	PRK09034, PRK09034, aspartate kinase; Reviewed	NA|198aa|up_2|NZ_CP009470.1_1475856_1476450_-	NA	NA|121aa|up_1|NZ_CP009470.1_1476959_1477322_+	TIGR01889, Pleiotropic_Regulator_Of_Virulence, staphylococcal accessory regulator family	NA|284aa|up_0|NZ_CP009470.1_1477510_1478362_+	NA	NA|337aa|down_0|NZ_CP009470.1_1481465_1482476_-	NA	cas2|100aa|down_1|NZ_CP009470.1_1482488_1482788_-	COG3512, COG3512, CRISPR-associated protein, Cas2 homolog [Defense mechanisms]	cas1|301aa|down_2|NZ_CP009470.1_1482801_1483704_-	cd09720, Cas1_II, CRISPR/Cas system-associated protein Cas1	cas9|1059aa|down_3|NZ_CP009470.1_1483703_1486880_-	cd09643, Csn1, CRISPR/Cas system-associated protein Cas9	NA|458aa|down_4|NZ_CP009470.1_1487439_1488813_-	COG0531, PotE, Amino acid transporters [Amino acid transport and metabolism]	NA|243aa|down_5|NZ_CP009470.1_1488815_1489544_-	COG2071, COG2071, Predicted glutamine amidotransferases [General function prediction only]	NA|170aa|down_6|NZ_CP009470.1_1489824_1490334_-	pfam00565, SNase, Staphylococcal nuclease homolog	NA|69aa|down_7|NZ_CP009470.1_1490471_1490678_+	NA	NA|88aa|down_8|NZ_CP009470.1_1491880_1492144_+	NA	NA|324aa|down_9|NZ_CP009470.1_1493008_1493980_+	pfam00565, SNase, Staphylococcal nuclease homolog
